BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Milić S, Lulić D, Štimac D, Ružić A, Zaputović L. Cardiac manifestations in alcoholic liver disease. Postgrad Med J 2016;92:235-9. [PMID: 26850503 DOI: 10.1136/postgradmedj-2015-133755] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Bergasa NV. Approach to the Patient with Liver Disease. Clinical Cases in Hepatology 2022. [DOI: 10.1007/978-1-4471-4715-2_2] [Reference Citation Analysis]
2 Mantle D, Hargreaves IP. Coenzyme Q10 supplementation in non-alcoholic fatty liver disease: an overview. Journal of Prescribing Practice 2020;2:200-204. [DOI: 10.12968/jprp.2020.2.4.200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Mantle D, Hargreaves IP. Coenzyme Q10 supplementation in non-alcoholic fatty liver disease: an overview. Gastrointestinal Nursing 2020;18:22-27. [DOI: 10.12968/gasn.2020.18.2.22] [Reference Citation Analysis]
4 Ismaiel A, Dumitraşcu DL. Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review. Front Med (Lausanne) 2019;6:202. [PMID: 31616668 DOI: 10.3389/fmed.2019.00202] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 15.5] [Reference Citation Analysis]
5 Kovalic AJ, Cholankeril G, Satapathy SK. Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations. Transl Gastroenterol Hepatol. 2019;4:65. [PMID: 31620647 DOI: 10.21037/tgh.2019.08.09] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
6 Mantle D, Hargreaves I. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview. Antioxidants (Basel). 2019;8. [PMID: 30781472 DOI: 10.3390/antiox8020044] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
7 Amirtharaj GJ, Natarajan SK, Pulimood A, Balasubramanian KA, Venkatraman A, Ramachandran A. Role of Oxygen Free Radicals, Nitric Oxide and Mitochondria in Mediating Cardiac Alterations During Liver Cirrhosis Induced by Thioacetamide. Cardiovasc Toxicol 2017;17:175-84. [PMID: 27131982 DOI: 10.1007/s12012-016-9371-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
8 Marconi C, Bellan M, Giarda P, Minisini R, Favretto S, Burlone ME, Franzosi L, Pirisi M. Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C. Ann Gastroenterol 2017;30:675-81. [PMID: 29118563 DOI: 10.20524/aog.2017.0190] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Toshikuni N, Tsuchishima M, Fukumura A, Arisawa T, Tsutsumi M. Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis. Gastroenterol Res Pract 2017;2017:9127847. [PMID: 28912806 DOI: 10.1155/2017/9127847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
10 Cowling RT. A sobering reminder that heavy drinking and heart failure do not mix. J Mol Cell Cardiol 2016;97:150-2. [PMID: 27181054 DOI: 10.1016/j.yjmcc.2016.05.008] [Reference Citation Analysis]